Consistent with this hypothesis, their data indicate that CARMA3 and Bcl10 are required for EGFR-induced NF-κB activation in both EGFR-expressing human cancer cell lines and mouse embryonic fibroblasts (41). Here, BCL10 is linked to cancer.